Aveanna Healthcare Holdings Inc (AVAH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $2.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
Aveanna Healthcare Holdings Inc (AVAH) P/E Ratio & Valuation History
Aveanna Healthcare Holdings (AVAH) trades at 14.9x trailing earnings and 1.0x sales. Its P/S of 1.0x is above its 5-year median of 0.4x. Its forward P/E is 12.0x. The median P/E across 11 similar companies is 28.8x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 24.2% higher over the next year. Its free cash flow yield is 7.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 14.9x |
| Forward P/E | 12.0x |
| Price to sales | 1.0x |
| Price to book | 7.9x |
| EV/EBITDA | 11.4x |
| Price to FCF | 13.5x |
| EV/FCF | 20.1x |
| PEG | N/A |
| FCF yield | 7.4% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.0x | 0.4x | N/A |
Valuation History
Over the 4 of the 5 year ends shown that have a P/E, its P/E ranged from 14.1x in 2025 to 91.4x in 2024. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $8.17 | 14.1x | 0.7x | 9.0x |
| 2024 | $4.57 | 91.4x | 0.4x | N/A |
| 2023 | $2.68 | N/A | 0.3x | N/A |
| 2022 | $0.78 | 78.0x | N/A | N/A |
| 2021 | $7.40 | 19.0x | 0.8x | 2.2x |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About AVAH
What is AVAH's forward P/E ratio?
Aveanna Healthcare Holdings has a forward P/E ratio of 12.0x.
Is AVAH stock overvalued?
GNG's valuation label for AVAH is Overvalued. Its P/E of 14.9x compares with a median of 28.8x across 11 similar companies.
What is AVAH's price to sales ratio?
Aveanna Healthcare Holdings has a price to sales ratio of 1.0x.
AVAH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors